UPDATE: FDA warns doc on CoreValve heart implant trial record-keeping issues
March 1, 2013 by Brad Perriello
A doctor participating in a clinical trial of Medtronic's CoreValve heart implant had "serious violations" of FDA record-keeping rules, prompting a warning letter from the federal watchdog agency.
UPDATED March 1, 2013, 2 p.m. EST with comment from Medtronic.
Hard on the heels of a regulatory win in Europe for 1 of its heart implants, Medtronic (NYSE:MDT) got some bad news from the FDA regarding another.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
Navigation
NEWS
Edwards Lifesciences' Perimount heart valve fares well in 25-year study
A clinical study tracking Edwards Lifesciences' Perimount heart valve over a 25-year span finds that...
St. Jude's Durata defibrillator 'immune' to Riata flaws?
St. Jude Medical's Durata implantable cardiac defibrillator leads should be "relatively immune...
Weight loss: GI Dynamics adds centers in Europe
GI Dynamics says another 5 centers in Europe are offering its EndoBarrier weight-loss device for...
Boston Scientific launches U.S. Parkinson's trial, cites interim EU data
Boston Scientific launches a U.S. clinical trial of its Vercise deep-brain stimulation treatment for...
